OH2 Injection in Melanoma

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(30 sites)

China

Peking University Cancer Hospital, Beijing, Beijing Municipality

Chongqing University Cancer Hospital, Chongqing, Chongqing Municipality

Fujian Cancer Hosptial, Fuzhou, Fujian

Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong